Hot Investor Mandate: Corporate VC Provides Services for Equity

10 Oct

The corporate VC is the strategic advisory and equity investment arm of a holding company and its CRO affiliate. The firm invests a portion of the normal cost of IND-enabling animal toxicology and pharmacology study services conducted by the CRO in companies and receives equity positions in exchange. The firm seeks to invest in companies located in the U.S. only.

The corporate VC is currently looking for companies developing therapeutics and considers both small molecules and biologics. The firm is open to most therapeutic indications, but generally is not interested in programs in the CNS or respiratory disease spaces. The firm is particularly interested in companies developing new therapies to treat ocular diseases where its CRO affiliate has highly specialized technology and significant expertise.

The firm does not lead investment rounds and acts only as a co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: